Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

FDA panel to review EMSAM on Oct 25th

Posted by jrbecker on September 16, 2005, at 15:31:54


http://www.fdaadvisorycommittee.com/FDC/AdvisoryCommittee/Stories/102505_chronicA.htm

Psychopharmacologic Drugs Advisory Committee To Review Need For Longer-Term Efficacy Data


FDA’s Psychopharmacologic Drugs Advisory Committee will meet Oct. 25 to discuss the need for longer-term efficacy data for proposed drug treatments for chronic psychiatric disorders and optimal study designs for obtaining valid information about longer-term benefits of drug treatment.

On Oct. 26 the committee will discuss whether or not dietary restrictions should be imposed on Somerset’s depression therapy Emsam (selegiline).

To watch a webcast of this meeting, click the button below. To arrange for live videoconferencing, or to order videotapes & DVDs, email webcasthelp@elsevier.com or call 800-627-8171.

Posted: Friday, September 16, 2005

Share
Tweet  

Thread

 

Post a new follow-up

Your message only Include above post

Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in
This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:jrbecker thread:555724
URL: http://www.dr-bob.org/babble/20050914/msgs/555724.html